Gonorrhea:
Symptoms, Testing, and Treatment

Gonorrhea symptoms in men and women, how testing works, antibiotic treatment, and why prompt care matters.

What Is Gonorrhea

Gonorrhea is a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. It is one of the most common STIs in the United States, with the CDC reporting approximately 650,000 new infections each year. The bacteria primarily infect the mucous membranes of the reproductive tract, including the cervix, uterus, and fallopian tubes in women, and the urethra in both men and women. Gonorrhea can also infect the throat, rectum, and eyes.

Gonorrhea is particularly concerning because many infected individuals, especially women, have no symptoms and may unknowingly transmit the infection to partners. Left untreated, gonorrhea can lead to serious complications including pelvic inflammatory disease (PID), infertility, and disseminated gonococcal infection, a condition where the bacteria spread through the bloodstream to the joints and other organs.

The good news is that gonorrhea is curable with appropriate antibiotic therapy. Early detection through routine STD screening is essential, particularly for sexually active individuals under 25, men who have sex with men, and anyone with new or multiple sexual partners.

Symptoms in Men

Men with gonorrhea are more likely to develop noticeable symptoms than women, though asymptomatic infection is still possible in approximately 10 to 15 percent of cases. Symptoms typically appear within 1 to 14 days after exposure, with most men noticing signs within 2 to 5 days.

Common symptoms of urethral gonorrhea in men include:

• A white, yellow, or greenish purulent discharge from the penis
• Burning or pain during urination (dysuria)
• Swollen or tender testicles (epididymitis), which is less common but can occur if the infection ascends
• Urethral itching or irritation
• Increased urinary frequency

Rectal gonorrhea in men who have sex with men may cause anal discharge, itching, soreness, bleeding, or painful bowel movements, though it is frequently asymptomatic. Pharyngeal (throat) gonorrhea is usually asymptomatic but may occasionally cause a sore throat. If you are experiencing any of these symptoms, prompt evaluation and treatment through a gonorrhea consultation can prevent complications and reduce further transmission.

Symptoms in Women

Gonorrhea in women is frequently asymptomatic or produces symptoms so mild that they are mistaken for a bladder infection or vaginal yeast infection. Up to 50 percent of women with gonorrhea have no symptoms at all, which is why routine screening is critical for early detection. When symptoms do appear, they typically develop within 1 to 14 days of exposure.

Symptoms of gonorrhea in women may include:

• Increased or abnormal vaginal discharge, which may be watery, creamy, or slightly green
• Burning or pain during urination
• Bleeding between menstrual periods or after sexual intercourse
• Pelvic or lower abdominal pain
• Painful intercourse (dyspareunia)

The silent nature of gonorrhea in women makes it especially dangerous. Untreated cervical gonorrhea can ascend to the uterus and fallopian tubes, causing pelvic inflammatory disease. PID can result in chronic pelvic pain, ectopic pregnancy, and tubal factor infertility. Women who are pregnant and infected with gonorrhea can also transmit the bacteria to the newborn during delivery, potentially causing gonococcal ophthalmia neonatorum, a serious eye infection. Regular STD screening is the most reliable way to catch asymptomatic infections early.

How Gonorrhea Spreads

Gonorrhea is transmitted through sexual contact with an infected partner. The bacteria spread through vaginal, anal, and oral sex, and can infect the genitals, rectum, and throat. Any sexually active person can contract gonorrhea, and having the infection once does not provide immunity against future infections. Reinfection is common, particularly when sexual partners are not treated simultaneously.

Key facts about gonorrhea transmission:

• The bacteria are transmitted through contact with infected genital, rectal, or pharyngeal secretions
• Ejaculation does not need to occur for transmission to happen
• A pregnant woman can pass gonorrhea to her baby during vaginal delivery
• Gonorrhea is not spread through casual contact such as hugging, sharing food, or using toilet seats
• Condoms, when used correctly and consistently, significantly reduce the risk of transmission

Because gonorrhea frequently co-occurs with other STIs, particularly chlamydia, providers often recommend testing for both infections simultaneously. Individuals diagnosed with gonorrhea should notify recent sexual partners so they can be tested and treated, helping to break the chain of transmission.

Testing and Diagnosis

Gonorrhea is diagnosed through laboratory testing, most commonly using a nucleic acid amplification test (NAAT). NAATs are the gold standard for gonorrhea detection due to their high sensitivity and specificity. Testing is simple and can be performed on a urine sample or a swab collected from the infected site (cervix, urethra, rectum, or throat).

Who should be tested for gonorrhea:

• All sexually active women under age 25, annually
• Women 25 and older with risk factors such as new or multiple partners
• Men who have sex with men, at least annually and more frequently based on risk factors
• Anyone with symptoms suggestive of gonorrhea
• Sexual partners of individuals diagnosed with gonorrhea
• Pregnant women at their first prenatal visit if at risk

Because gonorrhea can infect multiple body sites, providers may recommend testing at the throat and rectum in addition to urogenital testing for patients with relevant exposure history. Results are typically available within 1 to 3 days. A telehealth provider at InnoCre can order gonorrhea testing at a laboratory near you and review the results with you promptly.

Treatment

Gonorrhea is curable with appropriate antibiotic therapy. The current CDC-recommended treatment for uncomplicated urogenital, rectal, or pharyngeal gonorrhea is a single intramuscular injection of ceftriaxone 500 mg for patients weighing less than 150 kg, or 1 g for patients weighing 150 kg or more. This single-dose regimen achieves high cure rates and helps ensure treatment completion.

Important treatment considerations include:

• Because gonorrhea and chlamydia frequently co-occur, providers may add doxycycline 100 mg twice daily for 7 days if chlamydia has not been ruled out
• All sexual partners from the preceding 60 days should be evaluated and treated to prevent reinfection
• Patients should abstain from sexual activity for 7 days after treatment and until all partners have been treated
• A test of cure (repeat testing 7 to 14 days after treatment) is recommended for pharyngeal gonorrhea and for any case treated with an alternative regimen
• Retesting at 3 months is recommended for all patients to check for reinfection

Through a telehealth gonorrhea consultation, your provider can develop a treatment plan, order the appropriate medication, and coordinate follow-up testing to confirm the infection has cleared.

Antibiotic Resistance Concerns

Neisseria gonorrhoeae has demonstrated a remarkable ability to develop resistance to nearly every class of antibiotic used to treat it. Over the past several decades, gonorrhea has become resistant to sulfonamides, penicillins, tetracyclines, fluoroquinolones, and most recently has shown reduced susceptibility to cephalosporins and azithromycin. The CDC classifies antibiotic-resistant gonorrhea as an urgent public health threat.

This pattern of escalating resistance has significant clinical implications:

• Ceftriaxone injection remains the last reliably effective first-line treatment option
• Dual therapy with azithromycin was previously standard but was removed from guidelines after rising azithromycin resistance
• Treatment failures, while still rare, have been documented globally and are being closely monitored
• Self-treating with leftover antibiotics or incorrect regimens accelerates resistance and may not cure the infection

For these reasons, it is critical to follow current evidence-based treatment guidelines, complete the full prescribed regimen, and return for test-of-cure when recommended. If symptoms persist after treatment, contact your provider immediately, as this may indicate a resistant strain requiring alternative therapy. Responsible antibiotic use is essential to preserving the effectiveness of remaining treatment options.

Getting Tested Online

Telehealth provides a private and convenient pathway to gonorrhea testing and treatment. Many patients feel more comfortable discussing sexual health concerns from the privacy of their own home rather than in a waiting room. Through a virtual visit, a provider can evaluate your symptoms, assess your risk factors, and order laboratory testing at a facility near you without requiring an in-person office visit first.

At InnoCre Telehealth, our providers offer confidential gonorrhea evaluation and treatment for patients in Maryland, Washington, and Delaware. Here is how the process works:

• Schedule a same-day telehealth visit and discuss your symptoms or concerns with a board-certified provider
• Your provider orders a gonorrhea NAAT test at a local laboratory, often combined with screening for chlamydia and other STIs
• Visit the lab for a simple urine sample or swab collection -- no appointment needed at most locations
• Results are reviewed with you, typically within 1 to 3 days, and treatment is prescribed if positive
• Follow-up retesting is coordinated to confirm the infection has cleared

Early detection and treatment are the most effective ways to prevent gonorrhea complications and stop further spread. If you have been exposed to gonorrhea, are experiencing symptoms, or are due for routine STD screening, book a same-day telehealth visit to take the first step toward care.

Frequently Asked Questions